Li, X.; Yu, C.; Zheng, G.; Li, Y.; Cao, W.; Wang, F.
Development and Evaluation of Liposomal Celastrol-PROTACs for Treating Triple-Negative Breast Cancer. Pharmaceuticals 2025, 18, 1381.
https://doi.org/10.3390/ph18091381
AMA Style
Li X, Yu C, Zheng G, Li Y, Cao W, Wang F.
Development and Evaluation of Liposomal Celastrol-PROTACs for Treating Triple-Negative Breast Cancer. Pharmaceuticals. 2025; 18(9):1381.
https://doi.org/10.3390/ph18091381
Chicago/Turabian Style
Li, Xuebin, Chaoqun Yu, Gongyi Zheng, Yanghong Li, Weiguo Cao, and Fan Wang.
2025. "Development and Evaluation of Liposomal Celastrol-PROTACs for Treating Triple-Negative Breast Cancer" Pharmaceuticals 18, no. 9: 1381.
https://doi.org/10.3390/ph18091381
APA Style
Li, X., Yu, C., Zheng, G., Li, Y., Cao, W., & Wang, F.
(2025). Development and Evaluation of Liposomal Celastrol-PROTACs for Treating Triple-Negative Breast Cancer. Pharmaceuticals, 18(9), 1381.
https://doi.org/10.3390/ph18091381